Dhaka, Bangladesh (BBN)- Beximco Pharmaceuticals Limited (BPL) Tuesday announced that it has commenced supplying Oseltamivir capsules, Oseflu® (BPL’s generic version of Tamiflu®), to Latin and Central American countries.
The World Health Organization (WHO) estimates that 39 countries have officially reported 8,480 cases of influenza A (H1N1) infection.
“H1N1 appears to be more contagious than seasonal influenza and the new virus causing swine flu has been found to respond positively to Oseltamivir treatment,” the company said in a press statement.
Nazmul Hassan, Managing Director of Beximco Pharmaceuticals, commented: “BPL is the first company from Bangladesh to help combat the swine flu outbreak in Latin & Central American countries.”
Beximco Pharmaceuticals introduced Oseltamivir capsule Oseflu® in 2006 for the prevention and treatment of influenza including swine and bird flu.
In the same year BPL supplied Oseflu® to the Bangladesh and Myanmar governments for stockpiling to combat the Bird flu pandemic, the company said.
BBN/SS/SI/AD-20May09-1:51 am (BST)
